Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
General Hospital Psychiatry|May 5, 2018
Zinc in schizophrenia: A meta-analysisPeter Joe, Matthew Petrilli, Dolores Malaspina, et al.
BMC Infectious Diseases|June 13, 2022
Fatigue and quality-of-life in the year following SARS-Cov2 infectionPeter-Joe Noujaim, Damien Jolly, Claire Coutureau, et al.
Psychiatry Research|March 24, 2018
A pilot study assessing retinal pathology in psychosis using optical coherence tomography: Choroidal and macular thicknessPeter Joe, Meleha Ahmad, Gabriella Riley, et al.
Mediterranean Journal of Hematology and Infectious Diseases|May 26, 2022
Association between Heparin Dose and 6-Week Mortality in Patients with COVID-19Claire Coutureau, Philippe Nguyen, Maxime Hentzien, et al.
Psychiatry Research|January 16, 2018
Serum zinc levels in acute psychiatric patients: A case seriesPeter Joe, Mara Getz, Samantha Redman, et al.
Biology|June 24, 2022
Characteristics of COVID-19 Inpatients in Rehabilitation Units during the First Pandemic Wave: A Cohort Study from a Large Hospital in Champagne RegionAmandine Rapin, Peter-Joe Noujaim, Redha Taiar, et al.
Frontiers in Pharmacology|July 18, 2017
The Emerging Role for Zinc in Depression and PsychosisMatthew A Petrilli, Thorsten M Kranz, Karine Kleinhaus, et al.
Psychiatry Research|April 24, 2022
Patient-reported exposures and outcomes link the gut-brain axis and inflammatory pathways to specific symptoms of severe mental illnessSarah J Fendrich, Lauren R Koralnik, Mharisi Bonner, et al.
Schizophrenia Research|October 9, 2021
An integrative study of the microbiome gut-brain-axis and hippocampal inflammation in psychosis: Persistent effects from mode of birthPeter Joe, Jose C Clemente, Enrica Piras, et al.
Psychiatry Research|June 18, 2023
Gut and oral microbiome modulate molecular and clinical markers of schizophrenia-related symptoms: A transdiagnostic, multilevel pilot studyJakleen J Lee, Enrica Piras, Sabrina Tamburini, et al.
Pageof 1